In last trading session, Keros Therapeutics Inc (NASDAQ:KROS) saw 0.74 million shares changing hands with its beta currently measuring 1.29. Company’s recent per share price
During the last session, Keros Therapeutics Inc (NASDAQ:KROS)’s traded shares were 1.0 million, with the beta value of the company hitting 1.35. At the end
In last trading session, Keros Therapeutics Inc (NASDAQ:KROS) saw 0.57 million shares changing hands with its beta currently measuring 1.32. Company’s recent per share price
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne